DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Champions Oncology Q3 EPS $0.05 Beats $0.03 Estimate, Sales $9M Beat $8.13M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of $9 million which beat the

Benzinga · 03/12/2020 20:34

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of $9 million which beat the analyst consensus estimate of $8.13 million by 10.70 percent. This is a 39.97 percent increase over sales of $6.43 million the same period last year.